Cargando…
Novel strategies to reverse chemoresistance in colorectal cancer
Colorectal cancer (CRC) is a common gastrointestinal malignancy with high morbidity and fatality. Chemotherapy, as traditional therapy for CRC, has exerted well antitumor effect and greatly improved the survival of CRC patients. Nevertheless, chemoresistance is one of the major problems during chemo...
Autores principales: | Ma, Shu‐Chang, Zhang, Jia‐Qi, Yan, Tian‐Hua, Miao, Ming‐Xing, Cao, Ye‐Min, Cao, Yong‐Bing, Zhang, Li‐Chao, Li, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242875/ https://www.ncbi.nlm.nih.gov/pubmed/36645225 http://dx.doi.org/10.1002/cam4.5594 |
Ejemplares similares
-
Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023) -
Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
por: Lin, Xiang, et al.
Publicado: (2023) -
Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017) -
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies
por: Lai, Jinbao, et al.
Publicado: (2023) -
SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)